Arbutus Biopharma (0SGC.LSE) Q4 2025 Earnings

Nov 13Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.13
-0.08
-0.04
0.01

Details

Expected EPS
-0.03
Actual EPS
-0.04
Surprise EPS
-0.01
Surprise Percent
-33.33%

Description

⁨Arbutus Biopharma⁩ (⁦0SGC.LSE⁩) has reported earnings of ⁦-0.04⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts